Inventor
ANDERSSON CARL-MAGNUS A
SE26 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSSON CARL-MAGNUS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACADIA PHARM INC
20 patentsUS7601740B2Oct 13, 2009
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC60 citations99
US8921393B2Dec 30, 2014
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC41 citations98
US9566271B2Feb 14, 2017
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC17 citations96
US9211289B2Dec 15, 2015
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC20 citations96
US8377959B2Feb 19, 2013
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC26 citations96
US8008323B2Aug 30, 2011
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC25 citations96
US7994193B2Aug 9, 2011
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC29 citations96
US7732462B2Jun 8, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC36 citations96
US7659285B2Feb 9, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC33 citations96
US7713995B2May 11, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC30 citations95
US6815458B2Nov 9, 2004
Azacyclic compounds
ACADIA PHARM INC85 citations95
US10525046B2Jan 7, 2020
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC12 citations94
US8618130B2Dec 31, 2013
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC25 citations94
US6756393B2Jun 29, 2004
Azacyclic compounds
ACADIA PHARM INC77 citations94
US10028944B2Jul 24, 2018
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC15 citations92
US7923564B2Apr 12, 2011
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms
ACADIA PHARM INC26 citations92
US7732615B2Jun 8, 2010
N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
ACADIA PHARM INC29 citations92
US9296694B2Mar 29, 2016
Azacyclic compounds
ACADIA PHARM INC17 citations90
US6627645B2Sep 30, 2003
Muscarinic agonists
ACADIA PHARM INC25 citations89
US6951958B1Oct 4, 2005
Solid phase parallel synthesis of tertiary amines
ACADIA PHARM INC0 citations45